These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4451683)

  • 41. [Factors contributing to diabetes onset in prediabetic subjects].
    Luft R; Cerasi E; Wahren J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):47-54. PubMed ID: 4679579
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pathogenesis of hepatogenic diabetes mellitus].
    Ratzmann KP
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(5):361-70. PubMed ID: 4583562
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of fructose on glucose formation and oxydation in healthy subjects and patients with liver cirrhosis].
    Adlung J; Grazikowske H; Oltmanns D
    Infusionsther Klin Ernahr; 1977 Oct; 4(5):266-70. PubMed ID: 562317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucose metabolism in cirrhosis: a review with some perspectives for the future.
    Petrides AS; DeFronzo RA
    Diabetes Metab Rev; 1989 Dec; 5(8):691-709. PubMed ID: 2693018
    [No Abstract]   [Full Text] [Related]  

  • 45. [Tryptophan in hepatic encephalopathy].
    Esquivel López A; Austria Mireles R; Coronado Perdomo D
    Rev Gastroenterol Mex; 1983; 48(2):91-4. PubMed ID: 6622904
    [No Abstract]   [Full Text] [Related]  

  • 46. Ammonium and glucose metabolism in liver failure.
    Brown H; Brown ME; Covelli VH; McDermott WV
    JAMA; 1967 Sep; 201(11):873-4. PubMed ID: 6071907
    [No Abstract]   [Full Text] [Related]  

  • 47. Cirrhosis of the liver; impending hepatic coma and increased blood ammonium concentrations during protein hydrolysate infusion.
    WEBSTER LT; DAVIDSON CS
    J Lab Clin Med; 1957 Jul; 50(1):1-10. PubMed ID: 13439261
    [No Abstract]   [Full Text] [Related]  

  • 48. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.
    Perseghin G; Mazzaferro V; Sereni LP; Regalia E; Benedini S; Bazzigaluppi E; Pulvirenti A; Leão AA; Calori G; Romito R; Baratti D; Luzi L
    Hepatology; 2000 Mar; 31(3):694-703. PubMed ID: 10706560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 50. The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection.
    Lei L; Liu S; Li Y; Song H; He L; Liu Q; Sun S; Li Y; Feng Z; Shen Z
    Eur J Pharmacol; 2018 May; 826():17-23. PubMed ID: 29477658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nicergoline effect on insulin secretion in man.
    D'Onofrio F; Torella R; Sgambato S; Ungaro B
    Farmaco Prat; 1975 Mar; 30(3):153-62. PubMed ID: 1204823
    [No Abstract]   [Full Text] [Related]  

  • 52. Proinsulin and specific insulin responses to an oral glucose tolerance test in a healthy population.
    Chevenne D; Leger J; Levy-Marchal C; Noel M; Collin D; Czernichow P; Porquet D
    Diabetes Metab; 1998 Jun; 24(3):260-1. PubMed ID: 9690061
    [No Abstract]   [Full Text] [Related]  

  • 53. Insulin resistance and insulin secretion in chronic hepatitis C virus infection.
    Narita R; Abe S; Kihara Y; Akiyama T; Tabaru A; Otsuki M
    J Hepatol; 2004 Jul; 41(1):132-8. PubMed ID: 15246219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distal splenorenal shunt and insulin secretion, plasma glucagon, and glucose homeostasis in cirrhosis.
    Trevisani F; Bernardi M; Giancane S; Arienti V; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Nutrition; 1993; 9(2):133-9. PubMed ID: 8485325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Propranolol, hepatic encephalopathy and blood levels of ammonia in hepatic cirrhosis].
    Errico M; Giacobbe A; Facciorusso D; Simone P; Conoscitore P; De Maio ; Spirito F
    Minerva Dietol Gastroenterol; 1987; 33(3):223-6. PubMed ID: 3670672
    [No Abstract]   [Full Text] [Related]  

  • 56. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
    Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
    Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatic encephalopathy. The Danish Society of Hepatology].
    Sørensen M; Vilstrup H; Keiding S; Ott P;
    Ugeskr Laeger; 2007 Mar; 169(12):1106. PubMed ID: 17394817
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of glucose infusion on ammonia metabolism in liver failure.
    Sy BG; Dunea G; Steigmann F; Dubin A
    Am J Med Sci; 1968 Aug; 256(2):91-6. PubMed ID: 5672748
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on insulin loading in healthy subjects and liver patients].
    Waldhäusl W; Wewalka F
    Wien Klin Wochenschr; 1966 Oct; 78(43):734-6. PubMed ID: 5996746
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of glucagon on serum immunoreactive insulin concentration in patients with compensated liver cirrhosis].
    Czekalski S; Kozak W; Eder M; Gryczyńska M; Porawska J; Kozal H
    Pol Arch Med Wewn; 1977 Jul; 58(1):17-21. PubMed ID: 887460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.